The Valley Desk

NCT00343187 · Interventional trial

A Phase II Study of ACZONE™ (Dapsone) Gel, 5% As a Treatment For Tarceva® (Erlotinib)Related Rash

Overall registry status Terminated

Phase 2

Conditions Non-small-Cell Lung Cancer, Rash

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov